Cannabis,
Natural Resources,
British American Tobacco,
Certification,
BAT,
CFO,
OBX,
TSX,
Radar,
American Tobacco Company,
Note,
Investment,
Multimedia,
OGI,
Triangle,
Security (finance) Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million minority investment in Steady State LLC (d/b/a Open Book Extracts) (“OBX”) in the form of a convertible note.
Key Points:
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million minority investment in Steady State LLC (d/b/a Open Book Extracts) (“OBX”) in the form of a convertible note.
- “We are extremely excited to make our first Jupiter pool investment in Open Book Extracts, a company that we’ve had on our radar for quite some time,” said Paolo De Luca, Chief Strategy Officer of Organigram.
- The investment in OBX provides a further footprint in the U.S, which was a strategic priority set out in the Jupiter investment strategy.
- Through its investment in OBX, Organigram will gain valuable insights into the U.S. market and its consumers.
RTD,
Absorption,
CGMP,
Inhalation,
Titan Mare Explorer,
Infusion,
OBX,
NSF,
Drink,
B2B,
Chocolate,
THC NEW YORK, April 4, 2024 /PRNewswire/ -- Azuca, a trailblazer in advanced infusions within the regulated cannabis market, today announced a strategic collaboration with leading cannabinoid ingredient and product manufacturer Open Book Extracts (OBX) for the burgeoning hemp market, inclusive of federally-compliant, hemp-derived delta-9 THC.
Key Points:
- This collaboration harnesses Azuca's innovative TiME INFUSION® process and ACTiVATOR® product line with OBX's expertise in cannabinoid ingredients, product development, and finished goods manufacturing.
- Positioned as a "fast track" solution, Azuca and OBX will offer brands and manufacturers a streamlined pathway from concept to market, significantly reducing the time it takes to reach consumers.
- "At Azuca, we are dedicated to pushing the boundaries of innovation to deliver efficient, reliable, and delicious cannabis experiences for consumers.
- "Open Book Extracts is committed to making products that work for brands that care," shares Nicole Brown, OBX Chief Innovation Officer.
University of North Georgia,
Drink,
Lean Six Sigma,
The Home Depot,
NSF,
ISO,
Overalls,
Food safety,
State university system,
Environmental health,
Ace Hardware,
Hospira,
OBX,
Research,
United States Marine Corps,
Olson,
Master of Business Administration,
Organization,
Tablet,
ISO 9001,
Business administration,
Softgel,
Land O'Lakes,
CGMP,
Marine Corps League,
Supply chain,
Bachelor of Business Administration,
Quality control,
Growth,
HACCP,
Brenau University,
Bias,
EHS,
Safety,
Master,
Cosmetics,
Management,
Syngenta ROXBORO, N.C., April 25, 2023 /PRNewswire/ -- Open Book Extracts (OBX), an NSF cGMP and ISO 9001-certified manufacturer of high-quality cannabinoid ingredients and nutraceutical finished products, is pleased to announce Allen Olson will join the organization's leadership team as VP of Supply Chain, reporting to the CEO.
Key Points:
- ROXBORO, N.C., April 25, 2023 /PRNewswire/ -- Open Book Extracts (OBX), an NSF cGMP and ISO 9001-certified manufacturer of high-quality cannabinoid ingredients and nutraceutical finished products, is pleased to announce Allen Olson will join the organization's leadership team as VP of Supply Chain, reporting to the CEO.
- As a Lean Six Sigma black belt, Olson will leverage his experience to lead EHS, manufacturing, quality control, procurement, materials management, and logistics at OBX.
- With its breadth of products and services offerings, distinct growth strategy, and bias for innovation, OBX is poised for growth and continued category leadership," stated Allen Olson.
- "Olson brings decades of extensive supply chain and operations leadership experience in manufacturing companies, and has a special passion for continuous improvement.
Retrieved on:
Wednesday, February 8, 2023
CBDV,
Science,
Woman,
CBG,
University of Colorado Boulder,
NSF,
Cannabinoid,
Sleep,
Trial of the century,
ISO,
Acne,
Alzheimer's disease,
Quercetin,
Harvard University,
Curcumin,
PTSD,
CBC,
Pain,
Safety,
CBN,
Polyphenol,
CGMP,
OBX,
Depression,
Bipolar disorder,
Research,
Health,
FAMU,
CBD,
Relaxation,
Anxiety,
Partnership,
Dementia,
Quality of life,
Case Western Reserve University School of Medicine,
THCV,
Pharmaceutical industry,
Nursing,
Cancer ROXBORO, N.C., Feb. 8, 2023 /PRNewswire/ -- Open Book Extracts (OBX), an NSF cGMP and ISO 9001-certified manufacturer of the industry's most innovative and highest quality cannabinoid ingredients and finished products, is pleased to announce the launch of placebo-controlled trial of minor cannabinoid formulations to improve relaxation and calmness.
Key Points:
- To address this market need, OBX developed and tested distinct formulas designed to help people (1) unwind (relaxation) and/or (2) clear their mind (calmness).
- Based on scientific literature and real-world anecdotal feedback, six active ingredients were selected and formulated to promote two distinct mood states: relaxation and calmness.
- "The OBX Relaxation Study will test distinct formulations of cannabinoids and other bioactives, to better understand their ability to improve relaxation, stress, and overall well-being."
- To learn more about the OBX Relaxation Study and to see if you are eligible to participate, please visit: https://openbookextracts.com/relaxation-study/ .
Retrieved on:
Wednesday, January 4, 2023
Quality of life,
Dementia,
OBX,
Trial of the century,
Wayne State University School of Medicine,
History,
Research and development,
CBC,
Baillo,
GTI,
CBN,
Depression,
Health,
NSF,
Partnership,
Alzheimer's disease,
Innovation,
Research Triangle,
FAMU,
Harvard University,
IP,
Sleep,
Safety,
THCV,
Acne,
PTSD,
Woman,
R,
CBDV,
University of Colorado Boulder,
Food,
CGMP,
Pain,
Cannabinoid,
Bipolar disorder,
Science,
Doctor of Philosophy,
ISO,
Case Western Reserve University School of Medicine,
Clinical quality management system,
Management,
Fine chemical,
Pharmaceutical industry,
Cancer,
Research ROXBORO, N.C., Jan. 4, 2023 /PRNewswire/ -- Open Book Extracts (OBX), a leading ingredient manufacturer, product formulator, and manufacturer of the industry's most innovative and highest quality cannabinoid-enabled products, is pleased to announce the appointment of Andrea Baillo as Chief Scientific Officer. Andrea Baillo has broad research and innovation experience and will lead OBX's research and development (R&D) strategy.
Key Points:
- ROXBORO, N.C., Jan. 4, 2023 /PRNewswire/ -- Open Book Extracts (OBX), a leading ingredient manufacturer, product formulator, and manufacturer of the industry's most innovative and highest quality cannabinoid-enabled products, is pleased to announce the appointment of Andrea Baillo as Chief Scientific Officer.
- Andrea Baillo has broad research and innovation experience and will lead OBX's research and development (R&D) strategy.
- In her new role, Baillo will oversee all research and development efforts at OBX, including ingredient R&D, product development, and ingredient and product safety and efficacy research.
- Baillo is an experienced scientist with a demonstrated history of working in cannabis research, development, and manufacturing, cancer research, and food and beverage industries.
Retrieved on:
Wednesday, October 19, 2022
NSF,
Cannabis,
OBX,
Cannabinoid,
Edible,
Patient,
Drink,
Love,
Entrepreneurship,
Inflammation,
Technology,
Doctor of Philosophy,
Industry,
Pharmacy,
CPG,
Terpene,
Research Triangle,
IP,
Pain,
Liver,
DTL,
Anxiety,
Capsule,
Tablet,
Fine chemical Unlokt is a novel, protein-based infusion technology that uses a first-of-its-kind, fully water soluble powder that contains clean, all natural food grade ingredients.
Key Points:
- Unlokt is a novel, protein-based infusion technology that uses a first-of-its-kind, fully water soluble powder that contains clean, all natural food grade ingredients.
- With many emulsion-based edibles available today, most of the cannabinoids and terpenes are metabolized by the liver when ingested.
- OBX edibles with Unlokt uniquely incorporate the full spectrum of materials directly into the body's circulation allowing cannabis to be experienced as intended.
- Day Three Labs (DTL) is a cannabinoid CPG ingredient manufacturer specializing in the development and commercialization of novel cannabis product solutions.
Retrieved on:
Wednesday, October 12, 2022
NSF,
OBX,
Female,
THCV,
Technology,
Doctor of Philosophy,
Industry,
Research Triangle,
IP,
Face,
Literature,
Acne,
Capsule,
Tablet,
Male,
Cosmetics,
Medical device The study was conducted in collaboration with an industry leading dermatologist, Dr. Jeffrey Dover, and research dermatologist, Dr. Zoe Draelos. This is one of the first clinical evaluations of THCV in a topical preparation--there were no tolerability issues and promising efficacy results that will inform the design of future clinical trials.
Key Points:
- ROXBORO, N.C., Oct. 12, 2022 /PRNewswire/ -- Open Book Extracts (OBX), a leading global ingredient manufacturer and product development house for the industry's most innovative and highest quality cannabinoid-enabled products, completed its first cosmetic research study, an open-label, randomized, passive-control study examining the impact of topical serums containing Tetrahydrocannabivarin (THCV) on skin acne.
- Building on literature outlining THCV's anti-inflammatory topical properties, OBX conducted the study to explore THCV's therapeutic potential to improve skin acne.
- OBX was intentional about the inclusion of a diversity of skin tones in the study, in order to understand potential benefits for the products of interest across all skin types.
- The study was conducted in collaboration with an industry leading dermatologist, Dr. Jeffrey Dover , and research dermatologist, Dr. Zoe Draelos .
Retrieved on:
Thursday, September 15, 2022
OBX,
American Tobacco Company,
Tablet,
Safety,
Tetrahydrocannabivarin,
Cannabinoid,
ISO 9001,
CBG,
BAT,
BTV,
NSF,
CBD,
Research Triangle,
CBN,
CBT,
Review,
Cannabidivarin,
Toxicology,
IP,
Capsule,
CBC,
Shikimate pathway,
British American Tobacco,
Doctor of Philosophy,
Method,
Softgel,
Research,
ISO,
Drink,
Innovation,
Pharmaceutical industry,
Dietary supplement,
Fine chemical ROXBORO, N.C., Sept. 15, 2022 /PRNewswire/ -- Open Book Extracts (OBX), a leading global ingredient manufacturer and product development house for the industry's most innovative and highest quality cannabinoid-enabled products, today announces the completion of its Series C financing round.
Key Points:
- ROXBORO, N.C., Sept. 15, 2022 /PRNewswire/ -- Open Book Extracts (OBX), a leading global ingredient manufacturer and product development house for the industry's most innovative and highest quality cannabinoid-enabled products, today announces the completion of its Series C financing round.
- The funding secured could total between $20 million and $25 million (dependent upon achieving certain milestones).
- In addition to the funding, OBX and BAT have also signed a scientific collaboration agreement covering certain areas of future R&D.
- Established in 2020, BTV invests in high growth businesses, from seed funding to those looking for further, series B investment.
ISO,
Aspirin,
Chemistry,
CBD,
Cosmetics,
Water,
Capsule,
Industry,
Doctor of Philosophy,
NSF,
Pesticide,
Tablet,
THC,
History,
THCV,
Research,
Partnership,
IP,
Research Triangle,
CBG,
CBDV,
Nature,
CBT,
CTO,
Synthetic,
Shikimate pathway,
CBN,
Nalu,
Technology,
Cannabinoid,
Efficiency,
OBX,
CBC,
Fine chemical The partnership with OBX will allow Nalu Bio to advance its THCV production method from research and development to commercial-scale manufacturing using their proprietary and scalable synthesis platform.
Key Points:
- The partnership with OBX will allow Nalu Bio to advance its THCV production method from research and development to commercial-scale manufacturing using their proprietary and scalable synthesis platform.
- THCV will be the first cannabinoid available at commercial scale through this partnership, allowing OBX and Nalu Bio to offer the highest quality, most consistent dosage of THCV to consumers across the globe.
- Both OBX and Nalu Bio envision a range of additional cannabinoids to be released through this partnership.
- The partnership with Nalu Bio will allow OBX to provide the industry with the highest quality synthetic rare cannabinoids at the lowest cost.
ISO,
QSR,
CBD,
View,
Capsule,
Human resources,
Cannabidivarin,
Doctor of Philosophy,
NSF,
Enterprise resource planning,
Vocabulary,
International Organization for Standardization,
Tablet,
ERP,
Culture,
Research,
Accounting,
IP,
Research Triangle,
Infrastructure,
Quality management system,
CBG,
Safety,
Multimedia,
NSF International,
CBT,
Certification,
Achievement,
Quality assurance,
QMS,
International Organization (journal),
Shikimate pathway,
CBN,
Technology,
Method,
ISO 9001:2015,
Cannabinoid,
Efficiency,
ITIL,
Hechsher,
OBX,
Workflow,
Motivation,
Tetrahydrocannabivarin,
International Organization of Legal Metrology,
Business Growth Fund,
CBC,
Medical device,
Audit,
Risk management ROXBORO, N.C., July 21, 2022 /PRNewswire/ -- Open Book Extracts (OBX) is proud to announce the achievement of ISO 9001:2015 certification.
Key Points:
- ROXBORO, N.C., July 21, 2022 /PRNewswire/ -- Open Book Extracts (OBX) is proud to announce the achievement of ISO 9001:2015 certification.
- Through the ISO 9001:2015 certification, we have validated that the OBX Quality Management System supports this commitment," said Dave Neundorfer, OBX CEO.
- "Any company that has been through the certification process knows that achieving ISO 9001:2015 certification is demanding," said Chelsea Pipkin, OBX Vice President of Quality Assurance.
- The ISO 9001:2015 certification builds on accreditations OBX has recently received, including NSF/455-2 certification from global public health organization NSF International , USDA Organic Certification, and Kosher Certification.
